Technology NetworksMouse Model of Human Immune System Inadequate for Stem Cell StudiesTechnology NetworksA type of mouse widely used to assess how the human immune system responds to transplanted stem cells does not reflect what is likely to occur in p… Continue reading
CRISPR Therapeutics teams up with Massachusetts hospital in cancer treatment driveLife Sciences Intellectual Property Review (subscription)Gene-editing company CRISPR Therapeutics has partnered with the cancer centre at Massachusetts General Hospital t… Continue reading
Kaiser Health News |
‘Breakthrough’ Leukemia Drug Also Portends ‘Quantum Leap’ In Cost
Kaiser Health News A nurse reaches for blood samples taken from a patient receiving a kind of immunotherapy known as CAR T-cell therapy at the Fred Hutchinson Cancer Research Center in Seattle. Immune therapy is the hottest trend in cancer care. Its next frontier is … |
pharmaphorum |
Orchard’s gene therapy gains UK ‘promising innovative medicine’ status
pharmaphorum A UK biotech start-up has gained a sought after ‘promising innovative medicine’ (PIM) designation for its ultra-rare disease gene therapy. Orchard Therapeutics was only set up two years ago, but has now gained the PIM status from the UK’s medicines … |
MIT Technology Review |
Sickle-Cell Patients See Hope in CRISPR
MIT Technology Review The idea is that CRISPR could correct the genetic mutation responsible for sickle-cell so that patients’ bodies could make normal red blood cells, alleviating the pain and other severe symptoms associated with the disease. Researchers have already … |
Scope (blog) |
Current “humanized” mice not good models for studying stem cell transplants, say researchers
Scope (blog) These “humanized” mice have been useful models in some situations, such as the study of the human immune response to HIV infection or the transplantation of certain types of tissue. But recent research by cardiologist and stem cell expert Joseph Wu, MD … |